Table 1 Baseline patient characteristics
Characteristics | n = 75 | Description |
|---|---|---|
Gender (F/M) | 30/45 | F: Female, M: Male |
Age | 59 years | Average age at enrolment |
Survival (mean ∓ std) | 20.98 ∓ 11.67 months | Survival times for 53 patients have not been reported as they have been alive at the end of the follow-up and their prognostic status was considered as ‘long survival’. |
Tumour site (C/R/RS) | 45/24/6 | C: Colon, R: Rectum, RS: Rectosigmoid |
Chemotherapy regime | FOLFOX | All 75 patients received FOLFOX-based chemotherapy |
